INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Zoompass Holdings, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Jun 09, 2017
OTC Disclosure News Service
The securities litigation law firm of Brower Piven, A Professional
Corporation, announces that a class action lawsuit has been commenced in
the United States District Court for the District of New Jersey on
behalf of purchasers of Zoompass Holdings, Inc. (OTC MKTS: ZPAS)
(“Zoompass” or the “Company”) securities during the period between April
24, 2017 and May 24, 2017, inclusive (the “Class Period”). Investors who
wish to become proactively involved in the litigation have until July
31, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must
apply to be appointed lead plaintiff and be selected by the Court. The
lead plaintiff will direct the litigation and participate in important
decisions including whether to accept a settlement for the class in the
action. The lead plaintiff will be selected from among applicants
claiming the largest loss from investment in Zoompass securities during
the Class Period. Members of the class will be represented by the lead
plaintiff and counsel chosen by the lead plaintiff. No class has yet
been certified in the above action.
The complaint accuses the defendants of violations of the Securities
Exchange Act of 1934 by virtue of the defendants’ failure to disclose
during the Class Period that Zoompass unlawfully engaged in a scheme to
promote the Company’s stock and discovery of the conduct would subject
the Company to heightened regulatory scrutiny and potential criminal
According to the complaint, following a May 9, 2017 announcement that
the Company was requested by the OTC Markets Group, Inc. to comment on
recent trading and promotional activity, and a May 25, 2017 article
alleging that Zoompass has erroneously denied its involvement with a
scheme to promote the stock and hidden a pump-and-dump scheme, the value
of Zoompass shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in
Zoompass securities purchased on or after April 24, 2017 and held
through the revelation of negative information during and/or at the end
of the Class Period and would like to learn more about this lawsuit and
your ability to participate as a lead plaintiff, without cost or
obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html.
You may also request more information by contacting Brower Piven either
by email at email@example.com
or by telephone at (410) 415-6616. Brower Piven also encourages
anyone with information regarding the Company’s conduct during the
period in question to contact the firm, including whistleblowers, former
employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s. If you choose to retain counsel,
you may retain Brower Piven without financial obligation or cost to you,
or you may retain other counsel of your choice. You need take no action
at this time to be a member of the class.
Copyright © 2017 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.